Home | Welcome to Contract Pharma   
Last Updated Friday, December 19 2014

Print RSS Feed

Topics - Drug Development


Refine by Date:
From: To:
Published December 19, 2014
Will focus on treatment of hematological malignancies and solid tumors Read More »
Published December 19, 2014
BioChaperone Lispro could provide a new treatment option for diabetes Read More »
Published December 19, 2014
ONO-4059 shows clinical activity in CLL and NHL Read More »
Published December 18, 2014
Invests in a Thermo Fisher 16 twin screw extruder Read More »
Published December 18, 2014
Aims to identify cellular responses for oncology immunotherapies Read More »
Published December 18, 2014
To develop and commercialize highly potent analog CMX157 Read More »
Published December 17, 2014
Amunix will receive an option fee and is eligible for additional milestones Read More »
Published December 17, 2014
Includes a series of small molecule compounds against a cardiovascular drug target Read More »
Published December 17, 2014
To develop and commercialize Janssen products with ENHANZE technology Read More »
Published December 15, 2014
Broadens access to key biotech hubs Read More »
Published December 15, 2014
Aims to develop and commercialize long-acting hGH-CTP for growth hormone deficiency Read More »
Published December 10, 2014
Phase I study will evaluate Opdivo and mogamulizumab in solid tumors Read More »
Published December 9, 2014
Merck gains expanded access to Azymetric platform Read More »
Published December 8, 2014
Will collaborate with Spark to progress SPK-FIX clinical program in hemophilia B Read More »
Published December 8, 2014
Aims to enhance development and commercialization efforts Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On